[50] Dogan SE, Kukonmaz SM, Koc G, Aypar E, ulha C
Volek, J.S., Kraemer, W.J., Rubin, M.R., Gmez, A.L., Ratamess, N.A
The latter finding may suggest that the Glp1r -independent inhibitory effects of GLP-1(7-36) on glucagon secretion are actually mediated by the breakdown product GLP-1(9-36)
Plan costs increase to unsustainable levels, threatening a plans solvency Pain Point : GLP-1 medications, while effective for diabetes and weight loss, drive up health care costs for employers and their self-funded plans
10.1093/ejendo/lvad110 Eur J Endocrinol
Finally, therapeutic hypothermia (mild cooling to 3335 C) is a physical intervention that slows metabolic rate and has mitochondrial-protective effects (it reduces mitochondrial Ca 2+ overload and ROS production)